Page 86 - Quest Diagnostics News Today

Atticus Wealth Management LLC reduced its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 23.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 320 shares of the medical research company’s stock after selling 100 shares during the period. […]

Working Together To Create a Healthier World, One Life at a Time

The telehealth boom has gotten a boost from new weight loss drugs like Wegovy and Ozempic, taking advantage of loopholes for direct-to-consumer advertising.

Congress came together Saturday to secure a last-minute deal to continue government funding for 45 days and avoid a government shutdown, bucking the overwhelming consensus that a shutdown was inevitable.

Corundum Group Inc. purchased a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 1,466 shares of the medical research company’s stock, valued at approximately $206,000. A number of other institutional […]

FDA officials have long voiced concerns about the accuracy of some tests.

In the '80s, the formidable chemical pathologist (CP) safeguarded lab tests in the UK, and though times have changed, their role in guiding and educating medical professionals remains valuable.

Agency proposes tighter oversight of laboratory developed tests

The Food and Drug Administration says it plans to begin regulating laboratory-based medical tests. Its a multibillion-dollar industry that regulators say poses a growing risk to patients. The agency’s proposed

Breaking News, Sports, Manitoba, Canada